DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 3Dr. Reddy's Laboratories
02 2ADAPTIS
03 2American Regent
04 2Amneal Pharmaceuticals
05 2Amphastar Pharmaceuticals
06 2Amring Pharma
07 4Aurobindo Pharma Limited
08 2Avet Pharmaceuticals
09 4Biological E
10 2Caplin Point Laboratories Limited
11 2Endo International
12 3Exela Pharma Sciences, LLC.
13 8Farbe Firma
14 3Fresenius Kabi USA
15 2Fresenius SE & Co. KGaA
16 2GLAND PHARMA LIMITED
17 1Grindeks AS
18 1Hanlim Pharmaceuticals Inc
19 3Hikma Pharmaceuticals
20 1JAMP PHARMA
21 1Labiana Life Sciences S.A
22 1Lifespan Biotech
23 2MARCAN PHARMACEUTICALS INC
24 2Meitheal Pharmaceuticals
25 2Montage Laboratories
26 3Omega Laboratories Limited
27 2Pharmascience Inc.
28 2Pluviaendo
29 1Polifarma
30 2Sagent Pharmaceuticals
31 3Themis Medicare
32 2Umedica Laboratories
33 1Winston Medical Supply
34 1Zhejiang Xianju Pharmaceutical Co. Ltd
01 2Ampoule
02 1EYE DROP
03 1Eye Drops
04 2INJ
05 2INJECTABLE;INJECTION
06 1INJECTION
07 13Injection
08 1Injection Solution
09 4LIQUID
10 2Liquid Injection
11 4SOLUTION
12 40SOLUTION;INTRAVENOUS
13 2Vial
14 1Blank
01 4DISCN
02 3Generic
03 1Generic eCTD
04 2Prescription
05 36RX
06 30Blank
01 3BLOXIVERZ
02 1EYEFEEL
03 39NEOSTIGMINE METHYLSULFATE
04 2NEOSTIGMINE METHYLSULFATE INJECTION USP
05 1NEOSTIGMINE METHYLSULFATE INJECTION, USP
06 3NEOSTIGMINE OMEGA
07 2Neostigmine Methylsulphate
08 1Neostigmine Methylsulphate Fresenius 0.5Mg/Ml
09 1Neostigmine Methylsulphate Fresenius 2.5Mg/1Ml (Ampoules)
10 1Neotagmin 1
11 1Neotagmin 5
12 1Neotagmin P
13 1PMS-NEOSTIGMINE METHYLSULFATE INJ 0.5MG/ML
14 1PMS-NEOSTIGMINE METHYLSULFATE INJ 1MG/ML
15 1Rumintral
16 1Shushiming
17 16Blank
01 8Canada
02 1China
03 16India
04 1Latvia
05 2South Africa
06 1South Korea
07 1Taiwan
08 3Turkey
09 42USA
10 1Blank
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : NEOSTIGMINE METHYLSULFATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 5MG/10ML (0.5MG/ML)
Packaging :
Approval Date : 2018-07-10
Application Number : 209135
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : NEOSTIGMINE METHYLSULFATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 10MG/10ML (1MG/ML)
Packaging :
Approval Date : 2018-07-10
Application Number : 209135
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : NEOSTIGMINE METHYLSULFATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 3MG/3ML (1MG/ML)
Packaging :
Approval Date : 2022-07-06
Application Number : 216291
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : NEOSTIGMINE METHYLSULFATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 5MG/10ML (0.5MG/ML)
Packaging :
Approval Date : 2018-05-04
Application Number : 209182
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : NEOSTIGMINE METHYLSULFATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 10MG/10ML (1MG/ML)
Packaging :
Approval Date : 2018-05-04
Application Number : 209182
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NEOSTIGMINE METHYLSULFATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 5MG/10ML (0.5MG/ML)
Packaging :
Approval Date : 2018-06-15
Application Number : 210051
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NEOSTIGMINE METHYLSULFATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 5MG/10ML (0.5MG/ML)
Packaging :
Approval Date : 2017-09-25
Application Number : 209933
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NEOSTIGMINE METHYLSULFATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 10MG/10ML (1MG/ML)
Packaging :
Approval Date : 2017-09-25
Application Number : 209933
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NEOSTIGMINE METHYLSULFATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 5MG/10ML (0.5MG/ML)
Packaging :
Approval Date : 2022-11-25
Application Number : 208230
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NEOSTIGMINE METHYLSULFATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 10MG/10ML (1MG/ML)
Packaging :
Approval Date : 2022-11-25
Application Number : 208230
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NEOSTIGMINE METHYLSULFATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 5MG/10ML (0.5MG/ML)
Packaging :
Approval Date : 2017-04-26
Application Number : 208405
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NEOSTIGMINE METHYLSULFATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 10MG/10ML (1MG/ML)
Packaging :
Approval Date : 2017-04-26
Application Number : 208405
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : BLOXIVERZ
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 5MG/10ML (0.5MG/ML)
Packaging :
Approval Date : 2013-05-31
Application Number : 204078
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : BLOXIVERZ
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 10MG/10ML (1MG/ML)
Packaging :
Approval Date : 2013-05-31
Application Number : 204078
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : BLOXIVERZ
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 5MG/5ML (1MG/ML)
Packaging :
Approval Date : 2023-10-27
Application Number : 204078
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NEOSTIGMINE METHYLSULFATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 5MG/10ML (0.5MG/ML)
Packaging :
Approval Date : 2015-01-08
Application Number : 203629
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NEOSTIGMINE METHYLSULFATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 10MG/10ML (1MG/ML)
Packaging :
Approval Date : 2015-01-08
Application Number : 203629
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NEOSTIGMINE METHYLSULFATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 3MG/3ML (1MG/ML)
Packaging :
Approval Date : 2018-09-18
Application Number : 203629
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NEOSTIGMINE METHYLSULFATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 5MG/10ML (0.5MG/ML)
Packaging :
Approval Date : 2015-12-28
Application Number : 207042
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NEOSTIGMINE METHYLSULFATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 10MG/10ML (1MG/ML)
Packaging :
Approval Date : 2015-12-28
Application Number : 207042
Regulatory Info : RX
Registration Country : USA
